Eyewire News: The Podcast
Eyewire News: The Podcast

07.23.25

Harrow Adds Biosimilars to US Portfolio

Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

Show More